Abstract
As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.
| Original language | Italian |
|---|---|
| Pages (from-to) | 55-59 |
| Number of pages | 5 |
| Journal | Journal of Cardiovascular Echography |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2011 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Cite this
Le alterazioni elettrocardiografiche espressione di cardiotossicità. / Lombari, Maria Cristina; Tocchetti, Carlo Gabriele; Coppola, Carmela; Boccia, Angelo Sabato; Maurea, Nicola.
In: Journal of Cardiovascular Echography, Vol. 21, No. 2, 2011, p. 55-59.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Le alterazioni elettrocardiografiche espressione di cardiotossicità
AU - Lombari, Maria Cristina
AU - Tocchetti, Carlo Gabriele
AU - Coppola, Carmela
AU - Boccia, Angelo Sabato
AU - Maurea, Nicola
PY - 2011
Y1 - 2011
N2 - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.
AB - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.
KW - Antineoplastic treatments
KW - Arrhythmias
KW - Cardiotoxicity
KW - QT prolongation
KW - Target therapy
UR - http://www.scopus.com/inward/record.url?scp=80052829331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052829331&partnerID=8YFLogxK
U2 - 10.1016/j.jcecho.2011.04.002
DO - 10.1016/j.jcecho.2011.04.002
M3 - Articolo
VL - 21
SP - 55
EP - 59
JO - Journal of Cardiovascular Echography
JF - Journal of Cardiovascular Echography
SN - 2211-4122
IS - 2
ER -